Ginsenoside Rh2 mitigates doxorubicin‐induced cardiotoxicity by inhibiting apoptotic and inflammatory damage and weakening pathological remodelling in breast cancer‐bearing mice

OBJECTIVES: There are presently a few viable ways to reduce cardiotoxicity of doxorubicin (Dox). The combination of chemotherapy agents with natural compounds delivers greater efficacy and reduces adverse effects in recent researches for cancer treatment. Here, we examined the potential effect of gi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Jingang, Yun, Yeejin, Cui, Changhao, Kim, Sunchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201376/
https://www.ncbi.nlm.nih.gov/pubmed/35534947
http://dx.doi.org/10.1111/cpr.13246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201376/
https://www.ncbi.nlm.nih.gov/pubmed/35534947
http://dx.doi.org/10.1111/cpr.13246

Ejemplares similares